Zidovudine
Drug Status in USA : Approved
Drug Status in Canada : Approved
Indication : Why is this medication prescribed?
Asymptomatic and symptomatic HIV disease. Prophylaxis of maternal-foetal HIV transmission. Prophylaxis of HIV infection in neonates.
Contraindication: What are the special precautions to be followed?
Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patient
Hypersensitivity. Lactation. Neutropenia.Other Precaution to be observed while taking this medication
Hepatic or renal impairment. Elderly, pregnancy. Anaemia. Myelo suppression.
What are possible side effects of this medication ?
Anorexia, myalgia, insomnia, nausea, rash, abdominal pain, fever, anaemia, neutropenia, leucopenia. Dizziness, taste perversion, convulsions, myopathy, nail, skin and oral mucosa pigmentation, pancreatitis, fat redistribution. Lactic acidosis, severe hepatomegaly. Blood dyscrasias.
Drug Category/Class
- Anti-HIV Agents
- Antimetabolites
- Reverse Transcriptase Inhibitors
- Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
- Cytochrome P-450 CYP2C19 Inducers
- CYP2A6 Inhibitors
- CYP2A6 Inhibitors (strong)
- CYP2A6 Inhibitors (moderate)
- CYP2A6 Inducers
- CYP2A6 Inducers (strong)
- Cytochrome P-450 CYP2C9 Inhibitors
- Cytochrome P-450 CYP2C9 Inducers
- Cytochrome P-450 CYP2C8 Inhibitors
| Prescribed | Used in combination with other antiretroviral agents for the treatment of human immunovirus (HIV) infections. |
| Weight : | 267.2413 |
| Structure | Zidovudine |
 |
| Formula | C10H13N5O4 |
Zidovudine has 28 Brands listed
Search Generic Drugs alphabetically